| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/14/2007 | CN1911016A Synergistic microbicidal combination |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300172C Immunoglobulin antibody against SARS-CoV and its preparing method |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1299771C Colorstrum-based composition |
| 02/14/2007 | CN1299768C Preparation of diploid cell purified cerebritis B vaccine for human |
| 02/14/2007 | CN1299767C Production of fowl leukocyte interferon |
| 02/14/2007 | CN1299763C Method for preparing anti-hepatitis-B humanbody placenta transfer factor powder injecta |
| 02/14/2007 | CN1299734C Composition of traditional Chinese medicine for large intestine hygropyretic disease and its preparation method |
| 02/14/2007 | CN1299727C Chinese medicinal preparation for hepatitis and its preparing method |
| 02/14/2007 | CN1299725C Pharmaceutical composition for treating viral hepatitis type B and preparation technique thereof |
| 02/14/2007 | CN1299720C Medicine composition for curing cold |
| 02/14/2007 | CN1299712C Plumepoppy injection |
| 02/14/2007 | CN1299703C Process for preparing broad spectrum anti-virus medicine and its use |
| 02/14/2007 | CN1299692C Novel usage of jasminoidin |
| 02/14/2007 | CN1299691C Telithromycin suspension with a masked taste |
| 02/14/2007 | CN1299684C Antibacterial for aquatic animal and preparing method |
| 02/14/2007 | CN1299683C Celecoxib compositions |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/14/2007 | CN1299669C Mini pills for treating cold and its preparation method |
| 02/13/2007 | US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
| 02/13/2007 | US7176299 Compounds |
| 02/13/2007 | US7176276 Antimicrobial peptide and use thereof |
| 02/13/2007 | US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176228 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 02/13/2007 | US7176227 Amine compounds and use thereof |
| 02/13/2007 | US7176220 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176208 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 02/13/2007 | US7176206 Antibiotics |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/13/2007 | US7176196 Bicyclic heterocycles as HIV integrase inhibitors |
| 02/13/2007 | US7176191 Bi phosphate containing protonated compound with two end groups; disinfecting surfaces of surgical equipments and skin |
| 02/13/2007 | US7176178 Protein H and its fragments/derivatives are capable of interacting with nucleophosmin/B23, actin, NPM/B23, protein SET or hnRNP A2/B1 |
| 02/13/2007 | US7175987 administering to mammals mixtures of plant extracts from ginger, green tea, turmeric, horseradish and carriers |
| 02/13/2007 | US7175984 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 02/13/2007 | US7175850 Formulation for topical non-invasive application in vivo |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/13/2007 | CA2359744C Cephalosporins and homologues preparations and pharmaceutical compositions |
| 02/13/2007 | CA2194399C Novel carbapenem derivative |
| 02/12/2007 | CA2617123A1 Broad spectrum antibacterial compounds |
| 02/09/2007 | CA2618974A1 Nanoemulsion compositions having anti-inflammatory activity |
| 02/08/2007 | WO2007016556A1 Multifunctional polymers for promotion of opsonization of target cells and organisms |
| 02/08/2007 | WO2007016441A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007016292A2 Heterocyclic amides as biofilm modulators |
| 02/08/2007 | WO2007016134A1 BICYCLIC 6-ALKYLIDENE-PENEM B-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC |
| 02/08/2007 | WO2007015855A1 Hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007015824A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 02/08/2007 | WO2007015812A2 Hiv reverse transcriptase inhibitors |
| 02/08/2007 | WO2007015809A2 Hiv reverse transcriptase inhibitors |
| 02/08/2007 | WO2007015787A1 Hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007015540A1 Cytotoxic t-cell epitope peptide and use thereof |
| 02/08/2007 | WO2007015453A1 Lotion preparation containing pyridonecarboxylic acid derivative |
| 02/08/2007 | WO2007014941A2 Quinoline derivatives as antibacterial agents |
| 02/08/2007 | WO2007014926A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014925A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014924A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014923A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014922A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014921A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014920A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014919A1 Macrocylic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014918A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014885A1 Antibacterial quinoline derivatives |
| 02/08/2007 | WO2007014515A1 Use of hydroxybenzoic acid ester and analogues for the manufacture of a mendicament for the prevention and treatment of virus infection |
| 02/08/2007 | WO2007014514A1 Use of p-hydroxybenzoic acid and analogues for the manufacture of a mendicament for the prevention and treatment of skin mucosa virus infection |
| 02/08/2007 | WO2007014469A1 Hepatitis c antivirals |
| 02/08/2007 | WO2007014409A1 Pleuromutilin derivatives useful as antibacterials |
| 02/08/2007 | WO2006126171A3 New antibiotic derivatives |
| 02/08/2007 | WO2006104945A3 Hepatitis c therapies |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070032666 intermediate for side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones); 4-Bromo-5(bromomethylene)-3-(1-bromoethyl)-2(5H)-furanone from N-bromosuccinimide the 3-ethylfuranone |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032497 Fused-ring compounds and use thereof as drugs |
| 02/08/2007 | US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
| 02/08/2007 | US20070031510 Pharmaceutical combination preparation containing glycyrrhizine, zinc, and a compound comprising a thiol group or a group that is metabolized thereto |
| 02/08/2007 | US20070031507 Bactericide for MRSA |
| 02/08/2007 | US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV) |
| 02/08/2007 | US20070031442 Method and compositions for boosting immune response |
| 02/08/2007 | US20070031441 Immunotherapy based on dendritic cells |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | US20070031374 Treating cell proliferative disorders via administration of mixture comprising interleukin-21 and anti-cancer monoclonal antibody |
| 02/08/2007 | US20070031368 Chemokine conjugates |
| 02/08/2007 | US20070031344 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | CA2617869A1 Nanoparticles comprising antibacterial ligands |